Amit Arjyal Selected Research

Ofloxacin (Ofloxacine)

1/2020	Outbreak of acute undifferentiated febrile illness in Kathmandu, Nepal: clinical and epidemiological investigation.
4/2015	Undifferentiated febrile illness in Kathmandu, Nepal.
1/2013	Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial.
5/2012	Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever.
12/2010	Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amit Arjyal Research Topics

Disease

19	Typhoid Fever (Typhoid) 10/2021 - 06/2007
9	Fever (Fevers) 01/2020 - 06/2007
4	Infections 01/2017 - 12/2010
1	Bacteremia 01/2017
1	Endemic Flea-Borne Typhus (Typhus, Endemic Flea Borne) 04/2015
1	Hypoxia (Hypoxemia) 11/2008

Drug/Important Bio-Agent (IBA)

9	FluoroquinolonesIBA 10/2017 - 06/2011
6	Gatifloxacin (Zymar)FDA Link 06/2017 - 06/2007
5	Azithromycin (Zithromax)FDA LinkGeneric 10/2021 - 06/2017
5	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2020 - 12/2010
4	Cefixime (Suprax)FDA Link 01/2021 - 06/2007
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 06/2017 - 05/2016
2	VaccinesIBA 05/2016 - 09/2008
2	Ciprofloxacin (Cipro)FDA LinkGeneric 05/2012 - 12/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	AntigensIBA 01/2017
1	N- succinimidyl- 5- iodo- 3- pyridinecarboxylic acidIBA 01/2017
1	FlagellinIBA 01/2017
1	Immunoglobulin A (IgA)IBA 01/2017
1	ProteomeIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Cephalosporins (Cephalosporin Antibiotics)IBA 05/2016
1	Third Generation CephalosporinsIBA 05/2016
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2014
1	HLA-DRB1*04 antigenIBA 12/2014
1	Biomarkers (Surrogate Marker)IBA 06/2014
1	Nalidixic Acid FDA Link 01/2013
1	Chloramphenicol (Chloromycetin)FDA Link 06/2011
1	Drinking WaterIBA 11/2010
1	Biological ProductsIBA 05/2010
1	DNA (Deoxyribonucleic Acid)IBA 05/2010
1	Von Hippel-Lindau Tumor Suppressor ProteinIBA 11/2008

Therapy/Procedure

1	Time-to-Treatment 10/2017
1	Aftercare (After-Treatment) 05/2016
1	Duration of Therapy 06/2011